ORIC Pharmaceuticals (NASDAQ:ORIC) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research note released on Monday, Benzinga reports. Cantor...
RiceBran Technologies (NASDAQ:RIBT) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of RiceBran Technologies (NASDAQ:RIBT – Free Report) in a research report released on Monday morning. The firm issued a sell...
Benchmark Reaffirms “Buy” Rating for NeoGenomics (NASDAQ:NEO)
NeoGenomics (NASDAQ:NEO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Benchmark in a research note issued on Tuesday, Benzinga reports....
Funding Circle co-founder Samir Desai to leave board, marking end of an era
Samir Desai, co-founder and former CEO of Funding Circle, is stepping down from the board of the small business lender, distancing himself further from the...
Jefferies Financial Group Reiterates Hold Rating for Prestige Consumer Healthcare (NYSE:PBH)
Prestige Consumer Healthcare (NYSE:PBH – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Jefferies Financial Group in a note issued...
PROCEPT BioRobotics (NASDAQ:PRCT) and Revolutions Medical (OTCMKTS:RMCP) Critical Analysis
Revolutions Medical (OTCMKTS:RMCP – Get Free Report) and PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) are both medical companies, but which is the superior business?...